Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Nuvation Bio Q4 EPS $(0.10) Beats $(0.11) Estimate

Nuvation Bio (NYSE:NUVB) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 16.67 percent increase over losses of $(0.12) per share from the
byHappy Mohamed
March 15, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Nuvation Bio (NYSE:NUVB) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 16.67 percent increase over losses of $(0.12) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Asia Markets Mixed, Eurozone Climbs, And Crude Trading Near 5-Week Low – Global Markets Today While US Was Sleeping

By Akanksha Bakshi
October 6, 6:47 AM
On Thursday, October 5, the U.S. stock indexes closed lower, with investors anticipating Friday’s monthly employment data and potential insights into future interest rate directions. S&P 500’s performance was mixed; technology, healthcare, and financials rose, while consumer staples, industrials, and energy sectors declined.

ADIV